Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MGAT2 pseudogene 1 (MGAT2P1) is a human pseudogene related to the functional MGAT2 gene, which encodes an enzyme involved in N-glycan synthesis and lipid metabolism. However, as a pseudogene, MGAT2P1 does not encode a functional protein and is not implicated in any known biological processes, diseases, or as a target for therapeutic intervention. The functional MGAT2 gene (alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase) is well characterized, but MGAT2P1 itself is non-coding. There may be some confusion with MGAT2, a functional gene involved in N-glycan branching and lipid metabolism, which is a therapeutic target. MGAT2P1, by contrast, is a pseudogene and not a target. No relevant functional or clinical data exist for MGAT2P1. If the intention was to refer to the active MGAT2 enzyme, a different entry for the functional gene should be used. MGAT2P1 is a non-functional pseudogene, not a therapeutic target, and lacks biological and clinical significance in current scientific literature.
None (not a functional gene or protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MGAT2 pseudogene 1 (MGAT2P1).